NO20002050L - Aggregater av humaninsulinderivater - Google Patents

Aggregater av humaninsulinderivater

Info

Publication number
NO20002050L
NO20002050L NO20002050A NO20002050A NO20002050L NO 20002050 L NO20002050 L NO 20002050L NO 20002050 A NO20002050 A NO 20002050A NO 20002050 A NO20002050 A NO 20002050A NO 20002050 L NO20002050 L NO 20002050L
Authority
NO
Norway
Prior art keywords
aggregates
derivatives
human insulin
soluble
insulin derivatives
Prior art date
Application number
NO20002050A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002050D0 (no
Inventor
Svend Havelund
Per Balschmidt
Ib Jonassen
Thomas Hoeg-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20002050D0 publication Critical patent/NO20002050D0/no
Publication of NO20002050L publication Critical patent/NO20002050L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20002050A 1997-10-24 2000-04-18 Aggregater av humaninsulinderivater NO20002050L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK121897 1997-10-24
US6417097P 1997-11-04 1997-11-04
PCT/DK1998/000461 WO1999021888A1 (en) 1997-10-24 1998-10-23 Aggregates of human insulin derivatives

Publications (2)

Publication Number Publication Date
NO20002050D0 NO20002050D0 (no) 2000-04-18
NO20002050L true NO20002050L (no) 2000-06-23

Family

ID=26065414

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002050A NO20002050L (no) 1997-10-24 2000-04-18 Aggregater av humaninsulinderivater

Country Status (20)

Country Link
EP (1) EP1025125B1 (ru)
JP (1) JP2003525846A (ru)
KR (1) KR100539193B1 (ru)
CN (1) CN1240718C (ru)
AT (1) ATE243711T1 (ru)
AU (1) AU757933B2 (ru)
BR (1) BR9813128A (ru)
CA (1) CA2308705A1 (ru)
DE (1) DE69815877T2 (ru)
DK (1) DK1025125T3 (ru)
ES (1) ES2202899T3 (ru)
HU (1) HUP0004096A3 (ru)
IL (2) IL135400A0 (ru)
NO (1) NO20002050L (ru)
PL (1) PL195845B1 (ru)
PT (1) PT1025125E (ru)
RU (1) RU2218349C2 (ru)
UA (1) UA69393C2 (ru)
WO (1) WO1999021888A1 (ru)
ZA (1) ZA989722B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7316999B2 (en) 2000-06-02 2008-01-08 Novo Nordisk A/S Glucose dependent release of insulin from glucose sensing insulin derivatives
MXPA03010649A (es) 2001-05-21 2005-10-05 Nektar Therapeutics Administracion pulmonar de insulina modificada quimicamente.
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
ES2472421T3 (es) * 2003-08-05 2014-07-01 Novo Nordisk A/S Nuevos derivados de insulina
EP2264065B1 (en) * 2003-08-05 2017-03-08 Novo Nordisk A/S Novel insulin derivatives
UA103758C2 (ru) * 2004-07-19 2013-11-25 Биокон Лимитед Конъюгаты олигомеров инсулина, их композиции и применение
EP1888104A2 (en) * 2005-05-26 2008-02-20 Novo Nordisk A/S Acylated insulin with high purity
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
ATE557037T1 (de) 2006-02-27 2012-05-15 Novo Nordisk As Insulin derivate
JP2009539778A (ja) * 2006-06-08 2009-11-19 ダイアベコア メディカル インコーポレイテッド インスリンオリゴマー誘導体
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
ES2563038T3 (es) 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
ES2744384T3 (es) 2007-06-13 2020-02-24 Novo Nordisk As Formulación farmacéutica que comprende un derivado de insulina
ES2618073T3 (es) 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
EP2910571B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US9603904B2 (en) 2008-10-30 2017-03-28 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
CN103191416A (zh) * 2012-01-05 2013-07-10 四川大学 一种猪胰岛素超分子聚集体及其制备方法
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
MX2019006463A (es) 2016-12-16 2019-08-14 Novo Nordisk As Composiciones farmaceuticas que contienen insulina.
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
US6451970B1 (en) * 1996-02-21 2002-09-17 Novo Nordisk A/S Peptide derivatives

Also Published As

Publication number Publication date
CN1281466A (zh) 2001-01-24
PL340032A1 (en) 2001-01-15
KR20010031247A (ko) 2001-04-16
NO20002050D0 (no) 2000-04-18
DE69815877T2 (de) 2004-05-19
EP1025125A1 (en) 2000-08-09
RU2218349C2 (ru) 2003-12-10
ZA989722B (en) 1999-04-26
CA2308705A1 (en) 1999-05-06
KR100539193B1 (ko) 2005-12-27
IL135400A (en) 2007-08-19
BR9813128A (pt) 2000-08-15
ATE243711T1 (de) 2003-07-15
HUP0004096A2 (hu) 2001-05-28
DK1025125T3 (da) 2003-10-06
DE69815877D1 (de) 2003-07-31
WO1999021888A1 (en) 1999-05-06
AU757933B2 (en) 2003-03-13
IL135400A0 (en) 2001-05-20
ES2202899T3 (es) 2004-04-01
JP2003525846A (ja) 2003-09-02
HUP0004096A3 (en) 2001-12-28
PT1025125E (pt) 2003-11-28
AU9622198A (en) 1999-05-17
CN1240718C (zh) 2006-02-08
UA69393C2 (ru) 2004-09-15
PL195845B1 (pl) 2007-10-31
EP1025125B1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
NO20002050D0 (no) Aggregater av humaninsulinderivater
CA2209060A1 (en) Water-soluble or water-swellable polymers
TR199600322A2 (tr) Arilsülfonil hidroksamik asit türevleri.
BR9809025B1 (pt) polìmero anfótero, e, veìculo cosmeticamente aceitável.
CA2074186A1 (en) Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
DE3880465D1 (de) Wasserloesliche polymerdispersion.
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
DE69008454D1 (de) Nitrolsothiolderivate, ihre Herstellung und Verwendung.
SE9800806L (sv) Användning av kollagenas
HK1010196A1 (en) Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives.
HRP20010277B1 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
PT1140835E (pt) Derivados da 3,3-biarilpiperidina e 2,2-biarilmorfolina
AU3657100A (en) Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
TR199700601A3 (tr) Bir aromalandirici maddenin üretimi.
NO980303D0 (no) Vandige dispersjoner på basis av vannopplöselige polymerer
NO981484D0 (no) Olje-fri, vann-opplöselig, hydroksyetylcellulose, flytende polymerdispersjon
CA2314716A1 (en) Modified polysaccharides exhibiting altered biological recognition
DK1162941T3 (da) Solbeskyttelsesmidler
DE50001049D1 (de) Dekorative kosmetische zubereitungen
IS5731A (is) 4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun
TR199501104A2 (tr) Imidik asit türevleri.
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
FR2787329B1 (fr) Nouvelle application therapeutique des heparines de bas poids moleculaire

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application